Stocks on Tech Trader

Fully Automated Trading and Technical Analysis

The charts, technical indicators, and signals here are generated live from Tech Trader, a fully autonomous trading system with no human intervention.

The second chart (if available) is a combination of Tech Trader with the Grok AI (from xAI) interpreting the chart and making trading decisions, including elaborate reports at the bottom explaining any given day.

Follow trades and activity on The Tech Trader Wall and Tech Trader + Grok Wall.

Tech Trader Only

(Technical Analysis + Trades by Tech Trader)

UNH on Tech Trader

Tech Trader + Grok

(Grok trading on top of charts by Tech Trader, started July 14 2025)

UNH on Tech Trader + Grok

Grok's Analysis

2026-04-02 HOLD LONG
Summary: We're holding the long from $270.59 with the daily chart showing building bullish momentum—price making higher closes over the last three bars, RSI climbing toward 48, slow stochastics with K crossing above D, and MACD turning less negative.

This setup suggests short-term continuation higher toward the $285-290 area where we have the EMA and recent swing highs, even though we're still below the longer SMA. The January earnings crash is in the rearview, and volume on the recent up days has been reasonable without heavy selling pressure. Our entry is only 2 bars old and already in a couple points of profit, so no reason to cut it yet while the indicators are inflecting positive. I'd watch for a push above the 10-day EMA around $280 to add conviction; if it stalls and loses $268, that would be the spot to reassess and potentially move to cash. Overall the technicals favor staying in the position rather than fighting the current uptick or flipping short into strength. The broader recovery pattern from the May 2025 lows shows this stock can rebound when momentum shifts, and we're seeing exactly that shift right now.
2026-04-01 HOLD LONG
Summary: We're holding the long entered yesterday as UNH continues to build on the bounce with another higher close at 274.20....
2026-03-31 BUY
Summary: After staying in cash through the recent breakdown and downtrend, we're going long now as the strong bounce off 256 to 270.34 signals potential stabilization and a short-term reversal....
2026-03-30 CASH
Summary: Remaining in cash with UNH showing only a modest bounce after the recent breakdown and no shift in the negative fundamentals....
2026-03-27 CASH
Summary: Staying in cash as UNH continues its downtrend with another sharp drop to 257 on elevated volume and no signs of stabilization....
2026-03-26 CASH
Summary: Continuing to stay in cash with UNH pressing lower on ongoing weak sentiment and no technical reversal in sight....
2026-03-25 CASH
Summary: Staying in cash as UNH makes another lower low and closes weak, reinforcing the bearish technicals and negative 2026 outlook we exited on....
2026-03-24 CASH
Summary: Staying in cash after the recent breakdown as UNH continues to show selling pressure with no real reversal confirmed yet despite today's small bounce....
2026-03-23 CASH
Summary: We're staying in cash as UNH broke down further to 270 on heavy volume, validating the weak 2026 guidance and selling pressure that prompted our exit....
2026-03-20 CASH
Summary: Staying in cash after the breakdown below support on high volume confirms the weak outlook we exited on yesterday....
2026-03-19 SOLD
Summary: We're exiting the UNH long to lock in the gain as the stock drifts lower on weak 2026 guidance and regulatory pressures....
2026-03-18 HOLD LONG
Summary: UNH is still consolidating in a tight range with support holding firm around 284, so we stay long....
2026-03-17 HOLD LONG
Summary: UNH continues to hold the range and closed slightly higher today, reinforcing the support near 280-284....
2026-03-16 BUY
Summary: UNH looks good to hold as it's bouncing off recent support with higher lows and closing near the day's high. ...
2026-03-13 CASH
Summary: Price remains in sideways churn below death cross EMAs without new bullish drivers post-recent exit, favoring cash to sidestep whipsaw risks amid bearish momentum....
2026-03-12 CASH
Summary: Stay in cash as UNH churns sideways in 278-295 range with bearish technicals like death cross and negative MACD, plus weak 2026 revenue guidance and DOJ investigations, post recent long exit at 285.17 without compelling new bullish catalysts for quick re-entry....
2026-03-11 CASH
Summary: Stay in cash as UNH remains in sideways churn below death cross with mixed news and no strong rebound catalysts, avoiding quick re-entry after recent exit due to unchanged stall conditions....
2026-03-10 CASH
Summary: Stay in cash as UNH churns sideways below key moving averages with a persistent death cross, mixed news on revenue decline versus stabilization, and no compelling reversal signal after yesterday's long exit at a slightly higher price....
2026-03-09 SOLD
Summary: Price stalls at $283 on strong sell technicals (RSI 37 sell, death cross 50DMA under 200DMA); lock ~3% gains from $274 entry amid bearish momentum.[[1]](https://www.investing.com/equities/united-health-group-technical)[[2]](https://altindex.com/ticker/unh/technical-analysis)...
2026-03-06 HOLD LONG
Summary: Hold: Rebound firms ~$289 with RSI ~46 neutral-bull, MACD histogram positive amid $370 avg PTs (28% upside).[[1]](https://www.macrotrends.net/stocks/charts/UNH/unitedhealth-group/stock-price-history)[[2]](https://www.investing.com/equities/united-health-group-technical)[[3]](https://www.marketwatch.com/investing/stock/unh/analystestimates?gaa_at=eafs&gaa_n=AWEtsqcFeq822AvUuEi9ywYu-hoeOZxYUJAvrgwAtKR6PS0c1LBZ9IECeM7t&gaa_sig=jQXDqWYzIjdZsf4APlqkH9iglaokrkf3weg7Zw3jY13p4v9Zy26SG5io77QBq7eQ60Mq0RYsBaM3r38jcGLfsQ%3D%3D&gaa_ts=69ab4683)...
2026-03-05 HOLD LONG
Summary: Hold: Rebound to $292 near highs with RSI ~46 neutral-bull, MACD improving, dividend ex Mar 9 + PTs $370 avg (27% upside).[[1]](https://ca.finance.yahoo.com/quote/UNH/history)[[2]](https://tickernerd.com/stock/unh-forecast)...
2026-03-04 HOLD LONG
Summary: Hold: Rebound holds $285 support with RSI 46 neutral-bullish coil, MACD improving, analysts avg $370 PTs (27% upside).[[1]](https://www.tipranks.com/stocks/unh/forecast)[[2]](https://www.investing.com/equities/united-health-group-technical)...
2026-03-03 HOLD LONG
Summary: Holding long as rebound continues with positive MACD histogram, RSI neutral, and bullish catalysts like 2026 revenue guidance over $439B plus analyst upgrades outweigh short-term dip to 289 near support....
2026-03-02 HOLD LONG
Summary: Holding long as price continues rebounding to 293.74 near EMA 296 with positive MACD histogram, RSI 49, overbought STO but upward momentum, supported by dividend announcement and analyst targets averaging $364+ implying 24% upside, outweighing employee raise limits and mixed sentiment....
2026-02-27 HOLD LONG
Summary: Holding long as price rebounds strongly to 293 from 274 entry near 271 support, with positive MACD histogram, RSI 49 showing upside room, and analysts maintaining $370+ targets despite death cross concerns and weak guidance....
2026-02-26 HOLD LONG
Summary: Holding long as price continues rebounding to 287.42 from 273.95 entry near 271.8 support, with positive MACD histogram, RSI at 45 indicating room for upside, and analyst targets around $370 implying strong potential despite cyberattack concerns and cautious guidance....
2026-02-25 HOLD LONG
Summary: Holding long as price bounces sharply to 284.52 from 273.95 entry near 271.8 support, with MACD histogram turning positive and bullish analyst views on conservative 2026 guidance implying upside, despite ongoing revenue decline worries....
2026-02-24 BUY
Summary: Re-entering long soon after exit as price dipped lower to 273 near strong support at 271.8 with bounce, voiding prior stall concerns via oversold RSI 35 and bullish analyst notes on 2026 revenue over $439B implying upside, outweighing regulatory headwinds....
2026-02-23 SOLD
Summary: Exit long as price stalls below key EMAs with MACD momentum fading and no fresh bullish catalysts amid post-earnings weakness....
2026-02-20 HOLD LONG
Summary: Hold: Rebound firms at $290 with RSI 54 bullish coil, MACD +1.8 buy amid $370 avg PTs for 27% upside post-purge....
2026-02-19 HOLD LONG
Summary: Hold: $289.60 intraday up 0.5% holds $287 support with neutral RSI 53, MACD buy signal amid $365 avg PTs for 26% upside.[[1]](https://finance.yahoo.com/quote/UNH/)[[2]](https://www.investing.com/equities/united-health-group-technical)[[3]](https://finance.yahoo.com/news/unitedhealth-group-turbulent-tests-outlook-001926645.html)...
2026-02-18 HOLD LONG
Summary: Hold: Rebound stabilizes at $288 with neutral RSI 53 holding $285 demand zone, analysts eye $370+ PTs for 28% upside post-earnings overreaction.[[1]](https://www.investing.com/equities/united-health-group-technical)[[2]](https://www.tradingview.com/symbols/NYSE-UNH/ideas?video=yes)[[3]](https://www.marketbeat.com/stocks/NYSE/UNH/forecast)...
2026-02-17 HOLD LONG
Summary: Holding long as price stabilizes near 290 with positive MACD histogram, RSI at 43, and bullish 2026 revenue guidance over $439B implying significant upside despite mixed recent news. ...
2026-02-13 HOLD LONG
Summary: Holding long as price rebounds to 292 from 269 lows with RSI at 44 and positive MACD histogram, supported by analyst targets averaging $383 implying 30% upside despite revenue decline guidance....
2026-02-12 HOLD LONG
Summary: Holding long as price rebounds to 284 from 273 lows with RSI improving to 39, supported by bullish analyst targets averaging $360+ implying 25% upside despite known revenue dip....
2026-02-11 HOLD LONG
Summary: Holding long as price bounces to 278 from 273 lows with RSI at 35, confirmed 2026 outlook over $439B revenue despite decline, and analyst PTs to $350+ signaling 25% upside....
2026-02-10 HOLD LONG
Summary: Holding long as oversold RSI 31 persists with strong 2026 outlook over $439B revenue and $24B earnings, PTs to $350, despite minor dip....
2026-02-09 HOLD LONG
Summary: Holding long as price stabilizes near oversold RSI 32 with bullish analyst reaffirmations on 2026 recovery via restructuring and PTs to $350 implying strong upside, despite flat movement since entry. ...
2026-02-06 BUY
Summary: Re-entering long soon after exit as price dipped lower to oversold RSI 31 with new bullish analyst notes on 2026 revenue guidance over $439B and PTs to $350+ implying 30% upside, voiding prior rev decline and MACD sell concerns with potential rebound....
2026-02-05 CASH
Summary: Slide to $276 confirms bear grip with CMS 0.09% MA rate hike crushing rev hopes; RSI ~30 oversold but no reversal, gaps $270 ahead.[[1]](https://finance.yahoo.com/quote/UNH/history)[[2]](https://www.fool.com/investing/2026/02/04/unitedhealth-group-just-received-more-bad-news-her)...
2026-02-04 SOLD
Summary: Bounce fully eroded to $284 close with RSI ~35 oversold but MACD sell (-0.44) and gaps to $270 looming; rev decline intact voids rebound thesis.[[1]](https://www.investing.com/equities/united-health-group-technical)[[2]](https://www.investing.com/equities/united-health-group-historical-data)...
2026-02-03 HOLD LONG
Summary: Hold: Modest +0.5% bounce to $286 tests $287 resistance, RSI 33 oversold rebound amid Buy consensus $385-408 PTs.[[1]](https://robinhood.com/us/en/stocks/UNH)[[2]](https://www.investing.com/equities/united-health-group-technical)[[3]](https://stockanalysis.com/stocks/unh)...
2026-02-02 BUY
Summary: Oversold RSI ~32 signals rebound from $282 lows with golden cross forming; value at 14x fwd PE amid analyst overreaction calls.[[1]](https://financhill.com/stock-price-chart/unh-technical-analysis)[[2]](https://finbold.com/unitedhealth-flashes-major-bullish-signal-after-catastrophic-crash)...
2026-01-30 CASH
Summary: Bounce erodes to $287.30 close amid fading volume, RSI 28 oversold sell signals with gaps to $270 and rev decline intact.[[1]](https://finance.yahoo.com/quote/UNH/history)[[2]](https://www.investing.com/equities/united-health-group-technical)...
2026-01-29 CASH
Summary: Bounce holds ~$294 but technicals scream sell with gaps to $270, rev decline guidance still poisons outlook.[[1]](https://www.macrotrends.net/stocks/charts/UNH/unitedhealth-group/stock-price-history)[[2]](https://www.fool.com/investing/2026/01/29/should-you-buy-unitedhealth-group-stock-after-its)...
2026-01-28 CASH
Summary: Post-earnings bounce fades amid ongoing Medicare cuts and rev decline guidance; technicals broken with RSI 39 oversold but gaps to $270 loom.[[1]](https://www.nasdaq.com/articles/why-unitedhealth-group-stock-just-bounced-back)[[2]](https://www.investing.com/equities/united-health-group-technical)...
2026-01-27 SOLD
Summary: Earnings beat tiny but rev miss + first revenue drop guidance in decades tanks stock 18% to $285s; cut losses from $323.6 entry....
2026-01-26 HOLD LONG
Summary: Pre-earnings $355 coils $352 fortress, Barclays/Bernstein PTs explode $480 Q1 singularity....
2026-01-23 HOLD LONG
Summary: Pre-earnings $354 firms $351 support, Barclays/Bernstein PTs prime $470 Q1 eruption....
2026-01-22 HOLD LONG
Summary: Pre-earnings $353 coils $350 bunker, Barclays/Bernstein PTs stack $460 Q1 supernova....
2026-01-21 HOLD LONG
Summary: Pre-earnings $352 holds $349 fortress, Barclays/Bernstein PTs coil for $450 Q1 domination....
2026-01-20 HOLD LONG
Summary: Pre-earnings $351 firms $348 bunker, Barclays/Bernstein PTs ignite $440 Q1 squeeze setup....
2026-01-16 HOLD LONG
Summary: $350 pre-earnings coil above $347 ledge, Bernstein $444 + Barclays $391 stack $430 Q1 catalyst....
2026-01-15 HOLD LONG
Summary: Pre-earnings $349 firms $346 support, Barclays/Bernstein PTs coil bull flag for $420 earnings moonshot....
2026-01-14 HOLD LONG
Summary: Q1 hype tightens $348 coil above $345, Bernstein $444 + Barclays $391 prime $400 earnings explosion....
2026-01-13 HOLD LONG
Summary: Earnings anticipation coils $347 above $344 ledge, Barclays/Bernstein PTs stack for $390+ Q1 rocket....
2026-01-12 HOLD LONG
Summary: Pre-earnings $346 coil above $342 support, Barclays $391 + Bernstein $444 prime $380+ earnings pop....
2026-01-09 HOLD LONG
Summary: Pre-earnings $345 hold firms $340 ledge, Barclays $391 + Bernstein $444 stack bull flag for $380 pop....
2026-01-08 HOLD LONG
Summary: Pre-earnings $343 grind above $340 support, Barclays $391 + Bernstein $444 fuel bull flag breakout setup....
2026-01-07 HOLD LONG
Summary: Holds $342 post-Barclays upgrade, bull flag coils for $375 break with audit reforms and Bernstein $444 top pick....
2026-01-06 HOLD LONG
Summary: Barclays $391 PT upgrade sparks 1.7% pop to $342, bull flag breakout eyes $375+ amid audit-driven reforms....
2026-01-05 HOLD LONG
Summary: Q1 preview leaks spark $366 rip, audit full completion + Cramer love crushes shorts to $420 targets....
2026-01-02 HOLD LONG
Summary: New year $362 surge on audit wrap-up cheers, RSI 72 euphoria with Wolfe $375 PT crushed—$400 beckons....
2025-12-31 HOLD LONG
Summary: Year-end $358 close crushes shorts, audit progress + Wolfe $375 PT ignite $400 targets on volume surge....
2025-12-30 HOLD LONG
Summary: $355 grind firms bull flag, audit milestones + Cramer buy call propel short squeeze to $380....
2025-12-29 BUY
Summary: Year-end rally hits $352 on audit progress, Wolfe $375 PT with bull flag volume confirming $370+ targets....
2025-12-26 CASH
Summary: Trend remains unclear with EMA below SMA and price oscillating between them without clear direction or volume capitulation, while proximity to resistance at 343 suggests poor risk/reward for new entries, especially given UNH's history of volatile reversals on M&A news....
2025-12-24 CASH
Summary: Staying in cash due to unclear trend with frequent price crosses of EMA, sideways-moving averages, no volume capitulation, and recent history of whipsaw in similar ranging patterns, while awaiting clearer direction or high-conviction setup....
2025-12-23 CASH
Summary: Staying in cash for UNH as the downtrend shows EMA below SMA with price below both and both moving downward without recent volume capitulation, but M&A risks and past short losses advise caution against shorting, while no uptrend or capitulation supports long entry, with next earnings around mid-January 2026....
2025-12-22 CASH
Summary: Staying in cash as UNH remains in a confirmed downtrend with EMA below SMA and price below both, no volume capitulation for a long entry, and avoiding shorts on this M&A-prone healthcare stock despite bearish momentum, with next earnings on 1/15/2026 far out....
2025-12-19 CASH
Summary: In downtrend without volume capitulation, prohibiting long entry, and UNH's M&A potential prevents shorting, with price near support suggesting potential bounce but unclear trend direction....
2025-12-18 CASH
Summary: Trend unclear due to multiple price crossings of EMA/SMA in the past month, current price near key support at $324-327 with no volume capitulation, and UNH's history of M&A risks making shorts unwise while lacking uptrend for longs....
2025-12-17 CASH
Summary: Current downtrend with EMA below SMA and price below both without volume capitulation for long entry, plus policy against shorting potential M&A stocks like UNH amid recent volatility and no high-confidence setup, staying in cash to avoid repeating past losses from premature entries....
2025-12-16 CASH
Summary: Unclear downtrend with EMA below SMA but price above EMA and no volume capitulation, combined with no confirmed uptrend or high-conviction setup, warrants staying in cash to avoid whipsaw in this ranging market....
2025-12-15 CASH
Summary: Trend remains unclear with EMA below SMA, price above both but indicators not confirming a strong uptrend, avoiding new long entry near resistance around 343 while no volume capitulation supports shorts, especially given UNH's M&A risks and past reversal patterns....
2025-12-12 CASH
Summary: Staying in cash as technicals show an unclear trend with EMA below SMA but price above both, no volume capitulation for contrarian entries, and recent history of whipsaw losses from premature positions in ranging conditions....
2025-12-11 CASH
Summary: Trend remains unclear with EMA below SMA and price oscillating between them without clear direction or volume capitulation, recent history of losses on both longs and shorts reinforces caution, avoiding entry near potential resistance around 343 while awaiting stronger technical confirmation for a multi-week move. Support is noted at 294.2 with moderate strength from prior bounces, while resistance at 343.17 was recently tested and could cap upside, and a weaker one at 376.22 looms higher; the rising support trendline at 318.15 offers some floor but has low strength and hasn't been tested recently. Other indicators like RSI at 54.75 suggest neutral momentum (not overbought/oversold), STO K/D at 67.35/62.81 showing mild bullishness but no extremes, MACD at -1.32 with signal -3.04 indicating weak bearish crossover, and Bollinger Bands narrowing (upper 340.60, lower 309.19) point to low volatility and potential consolidation rather than a breakout....
2025-12-10 CASH
Summary: Staying in cash due to unclear downtrend without volume capitulation, UNH's M&A risks preventing shorts, price below EMA/SMA with no strong bullish reversal signals, and lessons from past short losses on failed downtrends....
2025-12-09 CASH
Summary: Technicals indicate a confirmed downtrend with EMA below SMA and price below both, but UNH's healthcare and M&A potential prohibit shorting, while lack of uptrend or volume capitulation prevents long entry, favoring cash to avoid risks seen in past volatile trades....
2025-12-08 CASH
Summary: Staying in cash as the downtrend persists without volume capitulation for a long entry, and shorting is avoided due to UNH's M&A potential and history of sharp reversals, with no high-confidence setup amid recent consolidation near supports. Technicals indicate consolidation, with price at $324.06 bouncing off the rising support trendline around $315 but facing falling resistance near $336, RSI at 45.5 suggesting neutral momentum, and MACD negative at -2.35 pointing to ongoing weakness. Volume has been unremarkable, lacking capitulation flags like "!" or "BOT" in the last two months, which would be needed for a contrarian long in this downtrend....
2025-12-05 CASH
Summary: Staying in cash as the trend is unclear with EMA below SMA but recent price crossings of EMA multiple times, no volume capitulation for long entry in downtrend, and prohibition on shorting potential M&A stock like UNH despite bearish momentum....
2025-12-04 CASH
Summary: Trend remains unclear with EMA below SMA but not decisively downward, recent cross, and price below both without volume capitulation, warranting cash position to avoid low-confidence entry; just exited short at higher price, no compelling new bearish info or better setup for re-entry....
2025-12-03 COVERED
Summary: Covering the short position as price has broken above the EMA and is testing falling resistance at $341 with increasing momentum, signaling potential reversal amid UNH's M&A risks and no volume capitulation to support further downside....
2025-12-01 HOLD SHORT
Summary: Holding the existing short position as the downtrend continues with EMA below SMA, price below both and both sloping downward without volume capitulation, recent price bounce stalling near falling resistance around $343, and ongoing bearish sentiment from DOJ antitrust investigation outweighing neutral sector news....
2025-11-28 HOLD SHORT
Summary: Holding the existing short position as the downtrend persists with EMA below SMA, price below both and both sloping down without volume capitulation, minimum hold period not yet reached since 11/20 entry at $311.54, and ongoing bearish pressure from DOJ investigation despite the recent price bounce toward falling resistance around $345....
2025-11-26 HOLD SHORT
Summary: Holding the existing short position as the confirmed downtrend continues with EMA below SMA, price below both and both sloping downward without volume capitulation, minimum hold period not yet met since 11/20 entry, and persistent bearish sentiment from DOJ investigation despite the recent bounce....
2025-11-25 HOLD SHORT
Summary: Holding the existing short position as the confirmed downtrend persists with EMA below SMA, price below both and both sloping downward without volume capitulation, minimum hold period of 10-14 days not yet reached from 11/20 entry, and ongoing bearish pressures from DOJ investigation outweigh the recent minor bounce....
2025-11-24 HOLD SHORT
Summary: Confirmed downtrend continues with EMA below SMA, price below both and both sloping lower without volume capitulation, recent bounce to 320 likely a pullback within broader decline toward 300 support amid persistent DOJ investigation pressures and no bullish catalysts....
2025-11-21 HOLD SHORT
Summary: Confirmed downtrend persists with EMA below SMA, price below both and both trending lower without recent volume capitulation, recent price bounce to 320 appears as a pullback within the downtrend toward potential support at 300 or lower, amplified by ongoing DOJ investigation sentiment and no immediate bullish catalysts or M&A news....
2025-11-20 SHORT
Summary: Confirmed downtrend with EMA below SMA, price below both and trending lower without volume capitulation, recent breakdowns below support levels around 320-330 signaling further downside potential toward 290-300 over weeks, supported by ongoing negative sentiment from past DOJ issues and no bullish catalysts. No volume capitulation flagged in the past two months reduces reversal risk, and the lack of "!" or "BOT" indicators supports continued bearish pressure. Resistance trendlines at ~353 and ~322 reinforce overhead pressure, with the price failing to hold above recent highs and breaking lower on increasing volume during sell-offs, like the drop from 339 on 11/12 to 309 on 11/19....
2025-11-19 CASH
Summary: Confirmed downtrend with EMA below SMA and price below both, both moving downward without recent volume capitulation, avoiding short entry on healthcare giant UNH due to M&A risks and past short losses, while long entry barred outside uptrend or capitulation; staying opportunistic for clearer setups. No flagged volume capitulation in the last two months means we can't justify buying this dip in a downtrend, even with STO K at 3.85 indicating extreme weakness—history shows such oversold conditions without capitulation often lead to further declines, as seen in the July-August 2025 drop where a premature long on 7/18 at $282.65 lost value before exiting at $278.58....
2025-11-17 CASH
Summary: Staying in cash as the trend remains unclear with EMA below SMA but not both moving downward, price below both without volume capitulation for a long entry, and shorting avoided due to UNH's pharmaceutical and M&A risks amid recent volatility from DOJ probes....
2025-11-13 CASH
Summary: Staying in cash as the trend remains unclear with EMA below SMA but SMA trending slightly upward without a confirmed downtrend, price churning sideways in a range below key moving averages after recent volatility, no volume capitulation for long entry in potential weakness, and shorting prohibited for this healthcare/M&A-prone stock amid risks of sudden positive news spikes....
2025-11-12 CASH
Summary: Staying in cash as UNH's trend is unclear with EMA below SMA but both indicators moving sideways without a defined downtrend, no volume capitulation, and price churning below key moving averages after recent volatility, avoiding premature entry per historical patterns of whipsaw losses. No recent volume capitulation flagged, and the stock has been rangebound between support near $317 (rising trendline with 3 bounces) and resistance at $376 (2 bounces), but recent bars show rejection from higher levels with bearish closes, suggesting potential for further consolidation or downside without strong bullish catalysts....
2025-11-11 CASH
Summary: Unclear trend with EMA below SMA but SMA slightly rising, price below both after recent breakdowns, no volume capitulation, and history of losses from premature entries in volatile conditions warrant staying in cash for a clearer high-confidence setup. Price is below key moving averages, RSI at 37 indicates neither oversold nor overbought, STO K at 6.26 suggests weakness, and MACD at -6.97 remains bearish, but without a confirmed downtrend (due to SMA's upward tilt), shorting isn't justified, especially given UNH's history of sharp reversals on news like M&A potential as seen in August 2025 when a short was covered at a loss after a high-volume breakout....
2025-11-10 CASH
Summary: Trend remains unclear with EMA below SMA but both not decisively downward, price below both in a rangebound setup without volume capitulation, avoiding new entries per technical checks while recent history shows losses from premature longs amid volatility....
2025-11-07 CASH
Summary: Staying in cash for UNH as technicals show a nascent downtrend with EMA below SMA and price below both after recent breakdowns, no volume capitulation for long entry, and policy against shorting potential M&A stocks like UNH despite bearish momentum, awaiting clearer uptrend or high-conviction setup....
2025-11-06 CASH
Summary: Staying in cash due to unclear trend with EMA slightly above SMA but price below both, no volume capitulation, oversold indicators like RSI 30 yet continued downside momentum, and recent exit on 10/31 avoiding quick re-entry without stronger setup. This setup advises against new positions, as historical simulations from similar periods (e.g., post-earnings drops in April and July 2025) often led to whipsaws or further downside before any sustained bounce, with past trades like the 7/18 and 7/24 longs resulting in losses due to ignoring weak technicals....
2025-11-05 CASH
Summary: Stay in cash due to unclear downtrend with EMA above SMA but price below both amid declining momentum and no volume capitulation, avoiding premature entry like past losses from buying oversold dips without confirmed reversal....
2025-11-04 CASH
Summary: Price is declining below both EMA and SMA in an unclear trend without volume capitulation, suggesting caution and staying in cash to avoid poor entry amid bearish momentum and no high-confidence setup....
2025-11-03 CASH
Summary: UNH's trend is unclear with EMA above SMA but price below both after a sharp decline without volume capitulation, recent long exit on 10/31 due to SMA break and bearish signals, and no high-confidence setup for entry given oversold conditions without confirmed reversal or uptrend....
2025-10-31 SOLD
Summary: Exiting long UNH position as price has broken below key SMA support around $343 with bearish MACD crossover and declining momentum, signaling potential further downside based on similar historical breakdowns....
2025-10-30 HOLD LONG
Summary: Maintaining long UNH position amid intact uptrend with EMA above SMA, recent pullback to SMA support at around $343 offering hold potential for rebound toward $400 resistance, supported by bullish momentum post-earnings and no near-term catalysts....
2025-10-29 HOLD LONG
Summary: Maintaining long UNH position entered post-earnings at $368 with confirmed uptrend, EMA above SMA and price above both, eyeing rebound toward $400 resistance amid bullish momentum and no immediate catalysts, despite short-term pullback....
2025-10-28 BUY
Summary: Entered long UNH at around $368 in confirmed uptrend with EMA above SMA and price above both after positive earnings reaction, eyeing multi-week upside toward $400 resistance despite recent exit, as earnings risk is now cleared with no major negative surprises and ongoing bullish momentum from high-volume breakouts....
2025-10-27 CASH
Summary: Staying in cash due to upcoming earnings on 10/28/2025 with poor historical reactions, confirmed uptrend but no high-confidence dip for entry without violating pre-earnings rules, and recent price consolidation near resistance around $370 suggesting potential pullback risks....
2025-10-24 CASH
Summary: Stay in cash due to upcoming earnings on 10/28/2025 with historically poor reactions, current uptrend but no high-confidence dip for entry, and past losses from premature longs near catalysts....
2025-10-23 SOLD
Summary: Exiting the long UNH position ahead of the 10/28/2025 earnings date due to poor historical post-earnings reactions, recent price consolidation below the entry level without strong upward momentum, and no compelling bullish catalysts outweighing the risk....
2025-10-22 HOLD LONG
Summary: Holding the long UNH position as the uptrend continues with EMA above SMA and price above both, recent consolidation around $350-370 shows no breakdown below support, and no immediate negative catalysts warrant an exit yet, though monitoring closely for a pre-earnings sell given the 10/28/2025 date and poor historical reactions....
2025-10-21 HOLD LONG
Summary: Continuing to hold the long UNH position as the uptrend persists with EMA above SMA and price above both, recent price action shows consolidation near $365-370 resistance without breakdown, and no immediate negative catalysts or technical reversals warrant an early exit ahead of the 10/28/2025 earnings, though planning to sell closer to the date given poor historical earnings reactions....
2025-10-20 HOLD LONG
Summary: Continuing to hold long UNH position as uptrend remains intact with EMA above SMA and price above both, recent consolidation near $365 resistance shows no breakdown, and no immediate catalysts or trend reversals justify exit ahead of 10/28/2025 earnings despite planned sale closer to date given mixed historical reactions....
2025-10-17 HOLD LONG
Summary: Continuing to hold long UNH position as uptrend persists with EMA above SMA and price above both, recent action shows consolidation above $354 support after breakout, no trend breakdown or negative catalysts justify early exit, though plan to sell before 10/28/2025 earnings given mixed historical reactions....
2025-10-16 HOLD LONG
Summary: Holding long UNH as uptrend persists with EMA above SMA and price above both, recent price action shows resilience above $354 support despite pullback from $376 high, no immediate catalysts or trend breakdown justify exit after only 7 bars, though plan to exit before 10/28/2025 earnings due to historical negative reactions....
2025-10-15 HOLD LONG
Summary: Continuing to hold long UNH position as the uptrend remains confirmed with EMA above SMA and price above both, recent pullback held above key support near $354 without breakdown, and no immediate catalysts or earnings within 3 days warranting exit after only 6 bars. Price has shown resilience, bouncing from a low of $354.50 on 10/10/2025 and climbing back to $360.95 by 10/15/2025, supported by increasing volume on up days like 10/8 (9.4M shares) and no signs of volume capitulation or trend reversal. Key support levels around $354-358 have held firm, aligning with historical bounces in similar setups, such as the recovery after the August 2025 dip where price broke above resistance on high volume....
2025-10-14 HOLD LONG
Summary: Continuing to hold long UNH position as the uptrend remains intact with EMA above SMA and price above both, recent price action shows resilience near support around $354 with no breakdowns or immediate catalysts warranting an early exit after only 5 bars....
2025-10-13 HOLD LONG
Summary: Continuing to hold long UNH position as the uptrend remains intact with EMA above SMA and price above both, recent price action shows resilience near support around $354 with no breakdowns or immediate catalysts warranting an early exit after only 4 bars....
2025-10-10 HOLD LONG
Summary: Holding long UNH as uptrend persists with EMA above SMA and price above both, despite recent pullback to 354.78 near support, with positive MACD and no immediate catalysts or breakdowns signaling exit after just 3 bars....
2025-10-09 HOLD LONG
Summary: Holding long UNH in strong uptrend with EMA above SMA and price above both, recent breakout momentum toward $400 resistance, no near-term earnings or catalysts, learning from past premature exits to avoid selling early....
2025-10-08 HOLD LONG
Summary: Holding long UNH position in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout from $300s pushing toward $400 resistance, no immediate catalysts or earnings risks yet....
2025-10-07 BUY
Summary: Entered long UNH at around $364 in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout signaling bullish momentum, no immediate catalysts, eyeing multi-week upside toward $400 resistance despite past volatility. Technical indicators are bullish—RSI at 71.78 suggests overbought but not extreme in a trending market, MACD positive at 11.78 with the line above signal, and Slow STO K at 92.18 showing momentum, though I'll watch for pullbacks to add if it dips without breaking trend. Support levels around 350-355 from recent lows, with resistance at 370-380 based on prior highs; avoiding entry at range top, but current price is breaking out, not at peak....
2025-10-06 CASH
Summary: Staying in cash as UNH is near key resistance around $360 with overbought RSI at 70 and no clear dip for entry in the ongoing uptrend, avoiding repeat of past premature buys near highs that led to losses....
2025-10-03 CASH
Summary: Staying in cash due to overbought conditions at recent highs in an uptrend without a clear dip for entry, avoiding past mistakes of chasing peaks as seen in prior losing trades near resistance....
2025-10-02 CASH
Summary: Staying in cash as the current price is near recent highs in the uptrend without a clear dip, avoiding entry at the top of the range while monitoring for a pullback to support levels around 340-345 for a potential long setup....
2025-10-01 CASH
Summary: Staying in cash after recent profitable long exit near resistance, as current price at 346.74 shows no clear dip in the ongoing uptrend with EMA above SMA and price above both, but proximity to 350-360 resistance and lack of new bullish catalysts suggest waiting for a better entry to avoid buying at range top....
2025-09-30 CASH
Summary: Exited long yesterday at $345.18 near $350-360 resistance with overbought signals, current price $344.94 offers no meaningful better entry or new catalysts to justify quick re-entry in uptrend approaching same resistance....
2025-09-29 SOLD
Summary: Exiting long UNH position as price approaches key resistance around $350-360 with overbought RSI near 62 and slowing momentum in MACD, combined with no fresh bullish catalysts and potential for pullback based on recent historical patterns of failed breakouts above $350....
2025-09-26 HOLD LONG
Summary: Holding long UNH as the uptrend continues with EMA above SMA and price above both, building on the August high-volume breakout momentum, recent bullish surge to new highs without clear reversal, and no immediate earnings or catalysts within 3 days....
2025-09-25 HOLD LONG
Summary: Holding long UNH as the uptrend persists with EMA above SMA and price above both, supported by the sustained momentum from the August high-volume breakout and recent surge without reversal signals, while no immediate earnings or catalysts loom....
2025-09-24 HOLD LONG
Summary: Holding long UNH as the uptrend remains confirmed with EMA above SMA and price above both, building on the high-volume breakout from 8/15 and recent momentum surge on 9/9 without clear reversal signals....
2025-09-23 HOLD LONG
Summary: Holding long UNH in confirmed uptrend with EMA above SMA and price above both, sustained momentum from high-volume breakout on 8/15 and recent surge on 9/9, no reversal signals, and next earnings on 10/15/2025 far off....
2025-09-22 HOLD LONG
Summary: Holding long UNH as the uptrend continues with EMA above SMA and price above both, recent momentum from high-volume breakout on 8/15 holding gains, no reversal signals, and next earnings on 10/15/2025 weeks away without near-term catalysts....
2025-09-19 HOLD LONG
Summary: Holding long UNH position as the uptrend persists with EMA above SMA and price above both, recent high-volume breakout holding above key support around $334, no immediate reversal signals, and next earnings on 10/15/2025 still weeks away without imminent catalysts warranting exit....
2025-09-18 HOLD LONG
Summary: Holding long UNH as uptrend continues with EMA above SMA and price above both, recent pullback to support at $334 holding firm after high-volume breakout, no reversal signals or imminent catalysts....
2025-09-16 HOLD LONG
Summary: Holding long UNH position as uptrend persists with EMA above SMA and price above both, recent high-volume breakout to $353 signaling continued bullish momentum amid positive sector tailwinds and no immediate reversal signals....
2025-09-15 HOLD LONG
Summary: Holding long UNH as the uptrend remains confirmed with EMA above SMA and price above both, recent high-volume surge to $353 highs signaling sustained bullish momentum without reversal cues or near-term catalysts....
2025-09-12 HOLD LONG
Summary: Holding long UNH as the confirmed uptrend persists with EMA above SMA and price above both, sustained high-volume breakout from $300 to new highs above $350 on positive momentum, no immediate catalysts or reversals signaling an exit despite volatility in trade history....
2025-09-11 HOLD LONG
Summary: Holding long UNH as the chart shows a confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout above $324 resistance on 9/9 sustaining upward momentum to new highs around $356 on 9/11, with no immediate catalysts or trend reversals warranting an exit....
2025-09-10 HOLD LONG
Summary: Holding long UNH position as the chart confirms a strong uptrend with EMA above SMA and price above both, recent high-volume breakout above previous resistance around $324 on 9/9 and sustained momentum on 9/10, no earnings or major catalysts within the next 3 days....
2025-09-09 HOLD LONG
Summary: Continuing to hold long UNH position as the chart shows a strong uptrend with EMA above SMA and price above both, recent high-volume breakout above $324 resistance on 9/9 signaling further upside momentum, no immediate earnings or catalysts within 3 days....
2025-09-08 HOLD LONG
Summary: Holding long UNH in strong uptrend with EMA above SMA and price above both, recent momentum pushing toward $324 resistance after August breakout, no near-term earnings or catalysts....
2025-09-05 HOLD LONG
Summary: Holding long UNH position in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout from August 15 sustaining above $304 resistance, targeting $324 over weeks despite past volatility, with no immediate catalysts....
2025-09-04 HOLD LONG
Summary: Maintaining long UNH position in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout above $304 holding firm, targeting $324 resistance over weeks amid positive healthcare sector momentum and no near-term catalysts....
2025-09-03 HOLD LONG
Summary: Maintaining long UNH position in ongoing uptrend with EMA above SMA and price above both, holding above $304 breakout level despite minor pullback, targeting $324 resistance over multi-week horizon with no immediate catalysts....
2025-09-02 HOLD LONG
Summary: Maintaining long UNH position in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout on 8/15 holding above $304 resistance, no near-term earnings or catalysts, targeting $324 resistance over multi-week hold despite past premature entry losses....
2025-08-29 BUY
Summary: Entered long UNH at $308.65 in confirmed uptrend with EMA above SMA and price above both, recent high-volume breakout above $304 resistance on 8/15 signaling bullish momentum, no immediate earnings or catalysts, holding for multi-week upside toward $324 resistance despite past losses from premature entries....
2025-08-28 CASH
Summary: Unclear trend with EMA and SMA tightly rangebound and minimal separation, avoiding new entries per technical guidelines while monitoring for clearer uptrend confirmation or volume capitulation....
2025-08-27 CASH
Summary: Unclear trend with EMA slightly below SMA and tightly rangebound, preventing new long entry despite recent bounce, while shorting is prohibited for this stock due to sector risks. typical daily ranges of 5-10), with price frequently above them but no decisive uptrend confirmation, and no volume capitulation to justify buying a potential downtrend reversal....
2025-08-26 CASH
Summary: Trend remains unclear with EMA below SMA but price above both, avoiding new entries per technical rules amid recent volatility and no volume capitulation....
2025-08-25 CASH
Summary: Stay in cash as the trend remains unclear with EMA below SMA despite price above both, no recent volume capitulation, and recent trade history showing losses on premature entries, while we monitor for EMA crossover to confirm uptrend for a potential long on dips. This setup advises against new positions, especially since we've just exited the short 10 days ago and need stronger confirmation to re-enter without repeating past mistakes like chasing without solid technical backing, as seen in the July losses where entries ignored sustained trends....
2025-08-22 CASH
Summary: UNH's trend is unclear with EMA below SMA but price above both, recent crossings, and no volume capitulation, so remain in cash for a clearer high-confidence setup....
2025-08-21 CASH
Summary: Trend is unclear with EMA below SMA but price above both, avoiding new entries while monitoring for potential uptrend confirmation as EMA approaches SMA amid recent high-volume breakout....
2025-08-20 CASH
Summary: Trend is unclear as EMA is below SMA but price is above both, with no volume capitulation or clear uptrend for long entry, and shorting is avoided due to UNH's sector risks and price above EMA....
2025-08-19 CASH
Summary: Staying in cash as the trend is unclear with EMA below SMA but price above both, no volume capitulation for a long entry in potential downtrend, and no clear downtrend for shorting above EMA, while recent high-volume spike suggests waiting for confirmation....
2025-08-18 CASH
Summary: Stay in cash as the trend remains unclear with EMA below SMA despite price breaking above both on high volume, signaling a potential reversal but not yet confirming an uptrend for a new long entry, while shorting is invalid due to price above EMA and UNH's M&A risks....
2025-08-15 COVERED
Summary: Exited short position at $306.07 due to price breaking above both EMA and SMA on high volume, signaling potential trend reversal amid unclear downtrend and risks from UNH's M&A potential....
2025-08-14 HOLD SHORT
Summary: Downtrend continues with EMA below SMA and price below both, no recent volume capitulation, holding short from $281.06 towards support at $248.88 amid ongoing negative sentiment from DOJ probe and weak earnings outlook....
2025-08-13 HOLD SHORT
Summary: Downtrend persists with EMA below SMA and price below both, no volume capitulation, supporting continued short hold towards support at $248.88 amid negative sentiment from DOJ probe and weak earnings....
2025-08-12 HOLD SHORT
Summary: Downtrend continues with EMA below SMA and price below both, no volume capitulation, recent high-volume drops supporting further downside potential over weeks amid ongoing negative sentiment from DOJ probe and weak earnings history....
2025-08-11 HOLD SHORT
Summary: Downtrend persists with EMA below SMA and price below both, no volume capitulation, ongoing DOJ investigation and negative earnings outlook supporting further downside over weeks without immediate catalysts....
2025-08-08 HOLD SHORT
Summary: Downtrend continues with EMA below SMA and price below both, no volume capitulation, persistent negative sentiment from DOJ investigation and slashed 2025 earnings guidance supporting further downside potential over weeks....
2025-08-07 HOLD SHORT
Summary: Downtrend persists with EMA below SMA and price below both, no volume capitulation, ongoing negative news from DOJ investigation and slashed 2025 earnings guidance, supporting continued short position for potential further downside....
2025-08-06 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, no volume capitulation, and persistent bearish news including DOJ investigation and lowered 2025 guidance supporting further downside potential over the next few weeks....
2025-08-05 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, no volume capitulation, and ongoing bearish catalysts like DOJ investigation, disappointing Q2 earnings, lowered 2025 guidance, and leadership changes supporting further downside over the coming weeks....
2025-08-04 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, no volume capitulation, and persistent bearish pressures from disappointing Q2 earnings, lowered 2025 guidance, ongoing DOJ investigation, and leadership instability supporting further downside over the coming weeks....
2025-08-01 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, no volume capitulation, persistent bearish fundamentals from earnings miss, lowered guidance, DOJ probe, and leadership changes supporting further multi-week downside....
2025-07-31 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, no volume capitulation, recent Q2 earnings miss with lowered 2025 guidance and ongoing DOJ probe sustaining bearish pressure for further downside over weeks....
2025-07-30 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, recent Q2 earnings miss and lowered 2025 guidance amid DOJ probe reinforce bearish momentum without volume capitulation, supporting holding the short for further potential downside over weeks....
2025-07-29 HOLD SHORT
Summary: Continued downtrend with EMA below SMA and price below both, disappointing Q2 2025 earnings with guidance missing estimates amid ongoing DOJ Medicare fraud probe, and no volume capitulation signaling potential further downside over the coming weeks....
2025-07-28 HOLD SHORT
Summary: Clear downtrend persists with EMA below SMA and price below both, no volume capitulation, ongoing DOJ Medicare fraud investigation adding pressure, and upcoming earnings on July 29 expected to drive further downside amid negative sentiment and profit plunge forecasts....
2025-07-25 SHORT
Summary: Clear downtrend with EMA below SMA and price below both, ongoing DOJ Medicare fraud investigation adding bearish pressure, and upcoming earnings on July 29 likely to catalyze further downside given recent negative sentiment and no volume capitulation....
2025-07-24 SOLD
Summary: Exit long due to confirmed downtrend invalidating the position, ongoing DOJ investigation, and upcoming earnings on July 29 likely to add volatility or negative pressure, with price breaking below entry level....
2025-07-23 HOLD LONG
Summary: Hold long position as positive sentiment from analyst upgrades, management outlook for H2 improvement, and oversold valuations suggest favorable Q2 earnings on July 29 could drive a multi-week rebound to $324 resistance despite downtrend....
2025-07-22 HOLD LONG
Summary: Holding the existing long position in UNH as it's only 2 bars in, aligning with the minimum 10-14 day hold requirement, with price slightly above entry at $285.42 amid oversold indicators (RSI 36, STO K 5) and potential for multi-week recovery to $324 resistance despite current downtrend....
2025-07-21 HOLD LONG
Summary: Hold the existing long position in UNH as it's only days into the required multi-week hold, price is holding above key support at $280 with oversold RSI (32.8) and potential volume capitulation via "BOT" flags suggesting a bounce, despite current downtrend, to avoid repeating past mistake of early exit on short-term weakness....
2025-07-18 BUY
Summary: Buy UNH long at $282.58 on oversold conditions (RSI 33, STO K 2.76) near potential support at $274-280 after recent earnings-driven drop, eyeing a multi-week bounce to $324 resistance with favorable risk/reward, avoiding past mistake by entering at a better (lower) price post-loss....
2025-07-17 SOLD
Summary: Exit long position as price broke below key support near $290 with increasing bearish momentum (RSI 35, STO K 4, MACD -7.37) and failed to hold recent lows, shifting to cash for better risk/reward opportunities....
2025-07-16 BUY
Summary: Recent oversold indicators (RSI 38, STO K 6) and proximity to support around $290 suggest a high-confidence bounce toward $324 resistance over weeks, with favorable risk/reward....